UNITED THERAPEUTICS Corp (UTHR)

UNITED THERAPEUTICS Corp
TickerUTHRBörseNasdaq
ISINUS91307C1027CIK0001082554
🔒 Mitglieder
Schluss · 27.07.2026
1T−0,1 %1W−0,3 %1M−2,7 %3M−6,9 %6M+11,5 %1J+73,4 %
GCS 53 → +0,0
TSI -14,0 · -12,5 ▼ 14.07.
8-K 5.02 23.07.26· 6T
Insider ▼ 28.07.26· 1T

Stammdaten

United Therapeutics Corporation ist ein Biotechnologieunternehmen, das sich mit der Entwicklung und Vermarktung von Produkten zur Erfüllung ungedeckter medizinischer Bedürfnisse von Patienten mit chronischen und lebensbedrohlichen Erkrankungen in den Vereinigten Staaten und international befasst. Seine Handelstherapien umfassen Remodulin zur Behandlung von Patienten mit pulmonaler arterieller Hypertension (PAH) zur Verminderung mit Anstrengung verbundener Symptome; Tyvaso, eine inhalative Formulierung des Prostazyklin-Analogons Treprostinil zur Verbesserung der Trainingsleistung bei PAH-Patienten und pulmonaler Hypertension in Verbindung mit interstitieller Lungenerkrankung (PH-ILD); Orenitram, eine Tablettenform von Treprostinil zur Verbesserung der Trainingskapazität bei PAH-Patienten; Unituxin, ein monoklonaler Antikörper zur Behandlung von hochrisiko-Neuroblastom; und Adcirca, ein oraler PDE-5-Hemmer zur Verbesserung der Trainingsleistung bei PAH-Patienten. Das Unternehmen entwickelt auch Tyvaso DPI, eine Trockenpulver-Inhalationsform von Tyvaso; Remunity Pump, eine kleine, leichte, langlebige Pumpe und separaten Controller; RemoPro und Ralinepag zur Behandlung von PAH; Aurora-GT, ein Gen-Therapie-Produkt zum Wiederaufbau der Blutgefäße in den Lungen; und Tyvaso PERFECT und TETON-Studien, bei denen es sich um Studien von Tyvaso bei Patienten mit Weltgesundheitsorganisation (WHO) Gruppe 3 pulmonaler Hypertension in Verbindung mit chronisch obstruktiver Lungenerkrankung (PH-COPD) handelt. Das Unternehmen hat Lizenz- und Kooperationsvereinbarungen mit DEKA Research & Development Corp. zur Entwicklung eines teilweise verwendbaren Systems für die subkutane Abgabe von Treprostinil; MannKind Corporation zur Entwicklung und Lizenzierung von Treprostinil-Inhalationspulver und dem Dreamboat-Gerät; und Arena Pharmaceuticals, Inc. zur Entwicklung von Ralinepag. Das Unternehmen wurde 1996 gegründet und hat seinen Hauptsitz in Silver Spring, Maryland. KI

Unternehmen & Branche

NameUNITED THERAPEUTICS Corp
TickerUTHR
CIK0001082554
BörseNasdaq
SektorGesundheit
IndustriePharmazeutische Erzeugnisse
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP91307C102
ISINUS91307C1027
TypCommon Stock
Marktkapitalisierung23,06 Mrd. USD
KGV (P/E)18,97
Beta0,58

Sitz & Kontakt

Sitz (Inkorporation)DE
Geschäftsadresse1000 SPRING ST, 20910 SILVER SPRING, MD
Telefon3016089292
EIN (IRS)52-1984749

Listing & Historie

Listing-BörsenNasdaq
Fiskaljahr-Ende31.12.
SEC-Filer-StatusLarge accelerated filer

Bewertung

KBV (P/B)3,25 vs. 2,46 (2021)
KUV (P/S)7,25 vs. 5,78 (2021)
FCF-Rendite4,5 % vs. 4,9 % (2021)
Buyback-Rendite4,3 %

Qualität & Bilanz

Bruttomarge87,9 % vs. 92,7 % (2021)
Operative Marge46,9 % vs. 33,0 % (2021)
Nettomarge41,9 % vs. 28,2 % (2021)
ROIC18,8 % vs. 12,0 % (2021)
Zinsdeckungsgrad76,5 vs. 29,9 (2021)
Forderungslaufzeit (DSO)40 T vs. 43 T (2021)
Lagerreichweite (DIO)174 T vs. 279 T (2021)
Verbindlichkeitslaufzeit (DPO)7 T vs. 11 T (2021)
Cash-Conversion-Cycle (CCC)207 T vs. 311 T (2021)

Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →

Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
Kennzahl20212022202320242025TTM*Verlauf
Bewertung
KBV (P/B)2,462,671,732,453,003,91
KUV (P/S)5,786,614,445,506,687,28
FCF-Rendite4,9 %5,2 %7,2 %6,8 %4,9 %4,4 %
Buyback-Rendite0,0 %0,0 %6,3 %4,7 %10,8 %
Qualität & Bilanz
Bruttomarge92,7 %92,2 %88,9 %89,2 %87,9 %86,6 %
Operative Marge33,0 %50,6 %50,9 %47,9 %46,9 %45,3 %
Nettomarge28,2 %37,6 %42,3 %41,5 %41,9 %40,6 %
ROIC12,0 %15,2 %16,5 %18,5 %18,8 %21,8 %
Zinsdeckungsgrad29,930,220,032,176,587,5

Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.

Externe Quelle: SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »

Glück Conviction Score™

UTHR UNITED THERAPEUTICS Corp
Conviction Score
53
Neutral
Risiko 36
Schwelle niedrighoch
Effektiv Neutral
Handelsvolumen Hoch
Insider
0,0
Keine Insider-Käufe
Institutionell
72,7
112 neu, 304 erhöht, 4494,5M $ netto
Aktivist
20,7
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)

Score-Verlauf (90 Tage)

Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.

Kursverlauf (24 Monate)

Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.

Technische Indikatoren

42.5
Technical-Score: 42.5 / 100 (informativ, keine Anlageempfehlung)
Bullisch-Anteil 18.2 % — 2 bullisch / 4 bärisch / 5 neutral

Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).

IndikatorSignalGewichtWertDetailBeitrag
Kurs vs SMA50Bärisch10 %548.11-3.7 % vs SMA50
Kurs vs SMA200Bullisch15 %512.81+3.0 % vs SMA200
EMA20 vs EMA50Bärisch5 %536.85EMA50: 544.16
MACD-HistogrammBärisch10 %-0.796Bearisch
RSI(14)Neutral10 %41.9Neutral (30–70)
Stoch %K(14)Neutral5 %20.2Neutral
ADX(14)+DINeutral10 %18.7+DI: 14.1 / −DI: 19.6
Z-Score(60)Bullisch5 %-1.51Extrem überverkauft
52W-PositionNeutral5 %78.6 %Hoch 596.76 / Tief 274.70
Bollinger(20,2σ)Neutral5 %23.7 %Upper 561.68 / Mid 539.58 / Lower 517.47
LinReg-Slope(60)Bärisch10 %-0.8098R²=0.73 / annualisiert -36.9 %

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-40532,49-21.299,58-3,7%
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.367523,15-715.152,06-123,4%
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.149528,20-606.904,56-104,7%
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.124530,29-596.047,98-102,9%
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.074524,04-562.817,56-97,1%
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-876525,02-459.918,05-79,4%
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-625529,41-330.882,38-57,1%
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-403530,97-213.981,03-36,9%
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.473526,34-775.294,70-133,8%
2026-07-28ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.369527,16-721.677,66-124,5%
2026-07-27ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-680525,81-357.551,55-61,7%
2026-07-27ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-890527,14-469.152,46-81,0%
2026-07-27ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-957533,53-510.589,55-88,1%
2026-07-27ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.121530,49-594.674,92-102,6%
2026-07-27ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.529532,38-814.004,43-140,5%
2026-07-27ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.797529,75-951.959,49-164,3%
2026-07-27ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.836531,65-976.107,20-168,4%
2026-07-27ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-650528,51-343.529,55-59,3%
2026-07-27ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-40535,04-21.401,60-3,7%
2026-07-24ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-820528,72-433.548,76-74,8%
2026-07-24ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-630534,39-336.668,09-58,1%
2026-07-24ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.115531,10-592.178,84-102,2%
2026-07-24ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-113535,03-60.457,89-10,4%
2026-07-24ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.818533,20-969.355,96-167,3%
2026-07-24ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.719532,27-1.447.229,35-249,7%
2026-07-24ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.285530,45-1.212.079,62-209,2%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.133529,08-1.128.524,65-194,7%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-249522,87-130.194,85-22,5%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-339523,72-177.539,72-30,6%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-387525,83-203.496,79-35,1%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.279529,86-1.207.540,00-208,4%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.989527,77-1.049.729,96-181,1%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.201530,84-637.540,16-110,0%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-552526,88-290.835,39-50,2%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-171524,86-89.751,18-15,5%
2026-07-23ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-200531,83-106.366,80-18,4%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-760529,80-402.644,50-69,5%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-790536,49-423.826,63-73,1%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-874528,91-462.264,89-79,8%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.211527,82-639.188,81-110,3%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.610526,84-1.375.057,88-237,3%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-80539,47-43.157,60-7,4%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-570537,60-306.433,94-52,9%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-489533,24-260.755,53-45,0%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-485526,04-255.130,95-44,0%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-400531,22-212.489,80-36,7%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-324534,19-173.075,94-29,9%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-120524,27-62.912,40-10,9%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-107535,40-57.288,07-9,9%
2026-07-22ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-680538,46-366.153,00-63,2%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.926530,50-1.021.743,00-176,3%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.605531,52-1.384.597,62-238,9%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-120524,37-62.923,97-10,9%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-160526,24-84.198,00-14,5%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-240527,46-126.590,40-21,8%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-341535,44-182.585,72-31,5%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-360532,47-191.688,41-33,1%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-509529,55-269.541,31-46,5%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-640533,58-341.489,79-58,9%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-839536,37-450.017,95-77,7%
2026-07-21ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.760534,61-940.922,05-162,4%
2026-07-20ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-80536,41-42.912,80-7,4%
2026-07-20ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-520535,20-278.306,29-48,0%
2026-07-20ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-889534,13-474.838,37-81,9%
2026-07-20ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-960529,85-508.656,86-87,8%
2026-07-20ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.660531,08-881.587,99-152,1%
2026-07-20ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.686533,03-898.683,18-155,1%
2026-07-20ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.831529,19-968.944,51-167,2%
2026-07-20ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.874532,07-997.104,61-172,1%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-251540,69-135.713,82-23,4%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-423538,70-227.871,20-39,3%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-720534,57-384.889,03-66,4%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-821539,63-443.033,44-76,4%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-892542,06-483.520,55-83,4%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.160537,45-623.438,06-107,6%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.110536,36-1.131.717,07-195,3%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.350535,53-1.258.485,63-217,2%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-240528,91-126.938,40-21,9%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-240530,83-127.399,99-22,0%
2026-07-17ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-293542,43-158.932,25-27,4%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-150536,29-80.443,07-13,9%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-440533,28-234.644,39-40,5%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-520532,14-276.711,50-47,7%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-720535,20-385.342,42-66,5%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.198534,31-640.100,62-110,5%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.400528,42-739.782,96-127,7%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.924530,14-1.019.998,79-176,0%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-3.057529,46-1.618.571,75-279,3%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-11537,11-5.908,21-1,0%
2026-07-16ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-80527,31-42.185,08-7,3%
2026-07-16MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-120529,81-63.577,20-11,0%
2026-07-16MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-80536,85-42.948,21-7,4%
2026-07-16MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-3.279534,21-1.751.679,18-302,3%
2026-07-16MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-1.519534,99-812.648,44-140,2%
2026-07-16MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-1.041535,88-557.850,87-96,3%
2026-07-16MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-861531,97-458.025,48-79,0%
2026-07-16MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-800532,94-426.351,52-73,6%
2026-07-16MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-600527,60-316.557,00-54,6%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-120523,97-62.876,80-10,8%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-80525,43-42.034,00-7,3%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-80521,82-41.745,60-7,2%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-48520,92-25.003,96-4,3%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-40534,09-21.363,60-3,7%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-40527,55-21.102,00-3,6%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-641529,03-339.105,67-58,5%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-825533,08-439.790,75-75,9%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.044531,03-554.390,62-95,7%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-3.295531,97-1.752.833,90-302,5%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-160533,22-85.314,80-14,7%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-120534,27-64.112,80-11,1%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-120529,66-63.559,60-11,0%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-120527,77-63.332,40-10,9%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-203523,20-106.210,09-18,3%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-189521,84-98.627,91-17,0%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-278530,97-147.609,05-25,5%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-280525,24-147.066,39-25,4%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-440524,40-230.734,02-39,8%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-577530,12-305.878,37-52,8%
2026-07-15ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-800532,06-425.647,44-73,4%
2026-07-14ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-959529,21-507.512,20-87,6%
2026-07-14ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.220527,06-643.009,91-111,0%
2026-07-14ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-3.492526,13-1.837.255,39-317,0%
2026-07-14ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.468525,16-770.940,46-133,0%
2026-07-14ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-107531,08-56.825,68-9,8%
2026-07-14ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-200532,60-106.520,40-18,4%
2026-07-14ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-554530,67-293.992,62-50,7%
2026-07-14ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-660528,13-348.568,51-60,1%
2026-07-14ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-840524,15-440.283,56-76,0%
2026-07-13ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-320539,60-172.673,41-29,8%
2026-07-13ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-40542,80-21.712,00-3,7%
2026-07-13ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-360541,10-194.795,89-33,6%
2026-07-13ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-409538,60-220.289,32-38,0%
2026-07-13ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-665537,66-357.545,36-61,7%
2026-07-13ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.020533,70-544.376,24-93,9%
2026-07-13ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.191535,47-1.173.213,46-202,4%
2026-07-13ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.223536,52-1.192.674,40-205,8%
2026-07-13ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.272534,63-1.214.669,36-209,6%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.578547,17-863.440,41-149,0%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-80553,47-44.277,60-7,6%
2026-07-10MALCOLM JANDirectorOpen Market Sale-325550,59-178.941,75-30,9%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-364544,54-198.211,90-34,2%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-400548,44-219.375,20-37,9%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-600540,37-324.222,66-55,9%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-676543,34-367.296,49-63,4%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-970541,47-525.225,80-90,6%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.438546,42-785.750,23-135,6%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.524545,54-831.408,75-143,5%
2026-07-10ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.870542,49-1.014.450,69-175,1%
2026-07-09ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.536549,01-843.272,60-145,5%
2026-07-09ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.863551,03-1.577.610,63-272,2%
2026-07-09ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.648552,38-910.323,23-157,1%
2026-07-09ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.452550,12-798.779,76-137,8%
2026-07-09ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-801553,29-443.185,05-76,5%
2026-07-09ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-640554,23-354.704,13-61,2%
2026-07-09ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-440548,16-241.189,08-41,6%
2026-07-09ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-120555,76-66.691,60-11,5%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.710553,42-946.350,42-163,3%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.490552,51-823.241,09-142,1%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.118554,45-619.880,13-107,0%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-925551,56-510.190,13-88,0%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-923549,52-507.210,01-87,5%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-785550,45-432.100,66-74,6%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-702557,82-391.590,62-67,6%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-291555,75-161.723,57-27,9%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-379556,64-210.966,90-36,4%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-637548,62-349.471,70-60,3%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-320560,79-179.453,60-31,0%
2026-07-08ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-220558,78-122.932,66-21,2%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-200553,12-110.623,22-19,1%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-241554,36-133.599,77-23,1%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-505560,49-283.047,80-48,8%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-596555,50-331.078,89-57,1%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-726556,55-404.058,20-69,7%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-800562,60-450.076,80-77,7%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.096557,78-611.323,59-105,5%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.875558,90-1.047.938,06-180,8%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-3.399559,76-1.902.628,66-328,3%
2026-07-07ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-62563,24-34.920,76-6,0%
2026-07-06ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-329550,78-181.205,14-31,3%
2026-07-06ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.098546,93-1.147.467,74-198,0%
2026-07-06ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.116549,87-1.163.514,76-200,8%
2026-07-06ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-131551,88-72.296,88-12,5%
2026-07-06ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-3.354549,03-1.841.458,69-317,8%
2026-07-06ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-135553,39-74.707,35-12,9%
2026-07-06ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-306553,90-169.494,81-29,2%
2026-07-06ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-1.031548,00-564.988,00-97,5%
2026-07-02MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-225556,36-125.180,75-21,6%
2026-07-02MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-258548,73-141.572,70-24,4%
2026-07-02MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-299554,45-165.779,17-28,6%
2026-07-02MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-384550,02-211.209,02-36,4%
2026-07-02MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-658548,00-360.584,79-62,2%
2026-07-02MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-990555,83-550.267,44-95,0%
2026-07-02MAHON PAUL AOfficer, EVP & GENERAL COUNSELOpen Market Sale-1.467551,30-808.751,38-139,6%
2026-07-02ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-40558,37-22.334,80-3,9%
2026-07-02ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-2.942555,67-1.634.790,26-282,1%
2026-07-02ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-118549,77-64.872,32-11,2%
2026-07-02ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-130548,75-71.337,62-12,3%
2026-07-02ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-192548,01-105.217,25-18,2%
2026-07-02ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-320557,63-178.440,42-30,8%
2026-07-02ROTHBLATT MARTINE ADirector, Officer, Chairperson & CEOOpen Market Sale-640551,59-353.019,20-60,9%

Fondsaktivität (Vorquartalsvergleich)

⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
BlackRock, Inc.5.399.64905.399.6493.201.883.611Neu+100,0%
Avoro Capital Advisors LLC3.010.00003.010.0001.569.833.400Neu+100,0%
WELLINGTON MANAGEMENT GROUP LLP2.264.24702.264.2471.342.653.186Neu+100,0%
VANGUARD CAPITAL MANAGEMENT LLC1.957.53901.957.5391.160.781.476Neu+100,0%
STATE STREET CORP1.843.96301.843.9631.093.433.180Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC1.787.01901.787.0191.059.666.527Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC1.233.02901.233.029729.920.363Neu+100,0%
Caption Management, LLC1.151.64501.151.645682.902.452Neu+100,0%
Janus Henderson Group Ltd.866.9300866.930514.015.988Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP862.4960862.496511.442.878Neu+100,0%
AQR CAPITAL MANAGEMENT LLC826.2260826.226486.424.477Neu+100,0%
CITADEL ADVISORS LLC697.8430697.843413.806.942Neu+100,0%
ASSETMARK, INC616.0500616.050365.305.135Neu+100,0%
FMR LLC528.3460528.346313.298.624Neu+100,0%
DIMENSIONAL FUND ADVISORS LP512.7390512.739304.029.148Neu+100,0%
DEERFIELD MANAGEMENT COMPANY, L.P.457.0000457.000270.991.860Neu+100,0%
NORTHERN TRUST CORP436.5660436.566258.874.907Neu+100,0%
BAILLIE GIFFORD & CO428.1270428.127253.870.748Neu+100,0%
MORGAN STANLEY409.2880409.288242.700.645Neu+100,0%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC343.6590343.659203.782.914Neu+100,0%
Pictet Asset Management Holding SA309.2200309.220183.306.233Neu+100,0%
MILLENNIUM MANAGEMENT LLC304.7720304.772180.723.701Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC300.4810300.481178.179.223Neu+100,0%
Swedbank AB322.995327.122-4.127175.008.379Reduziert-1,3%
FULLER & THALER ASSET MANAGEMENT, INC.280.4050280.405166.274.383Neu+100,0%
FRANKLIN RESOURCES INC277.9830277.983164.838.454Neu+100,0%
FIRST TRUST ADVISORS LP270.5780270.578160.447.289Neu+100,0%
Eversept Partners, LP264.2710264.271156.707.418Neu+100,0%
CITIGROUP INC255.6200255.620151.577.548Neu+100,0%
FRONTIER CAPITAL MANAGEMENT CO LLC252.7020252.702149.847.285Neu+100,0%
IMC-Chicago, LLC243.0620243.062144.130.905Neu+100,0%
Sofinnova Investments, Inc.240.3700240.370142.534.603Neu+100,0%
UBS Group AG236.7290236.729140.375.563Neu+100,0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC207.3090207.309122.930.093Neu+100,0%
JANE STREET GROUP, LLC203.3590203.359120.587.820Neu+100,0%
BANK OF AMERICA CORP /DE/199.4260199.426118.255.868Neu+100,0%
DEUTSCHE BANK AG\198.7770198.777117.870.786Neu+100,0%
Nuveen, LLC190.6970190.697113.079.508Neu+100,0%
Soleus Capital Management, L.P.187.1870187.187110.998.147Neu+100,0%
Legal & General Group Plc186.7940186.794110.765.107Neu+100,0%
ALLIANCEBERNSTEIN L.P.220.6340220.634107.503.917Neu+100,0%
Point72 Asset Management, L.P.170.7030170.703101.223.465Neu+100,0%
FIFTH THIRD BANCORP164.9780164.97897.828.539Neu+100,0%
Amundi147.5990147.59987.523.256Neu+100,0%
Allspring Global Investments Holdings, LLC146.5240146.52483.558.242Neu+100,0%
Qube Research & Technologies Ltd123.4410123.44173.198.044Neu+100,0%
RHUMBLINE ADVISERS122.4860122.48672.631.676Neu+100,0%
Epoch Investment Partners, Inc.120.6820120.68271.562.013Neu+100,0%
Swiss National Bank120.0550120.05571.190.214Neu+100,0%
D. E. Shaw & Co., Inc.119.1060119.10670.627.476Neu+100,0%

Top-Fondshalter (Stand: 30.06.2026)

⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".

FondsAnteileVorquartal (Stk)ΔWert (USD)Anteil (%)StimmkontrolleVerlauf
Swedbank AB322.995327.122-1,3%175.008.37922,72100 %16 Q
Robeco Institutional Asset Management B.V.123.056127.902-3,8%66.675.4318,6676 %17 Q
Retirement Systems of Alabama89.49698.378-9,0%48.491.6186,30100 %17 Q
Assenagon Asset Management S.A.84.53847.183+79,2%45.805.2255,95100 %17 Q
ATWOOD & PALMER INC61.47962.436-1,5%33.310.9874,33100 %17 Q
Polaris Capital Management, LLC53.45096.650-44,7%28.960.8143,76100 %17 Q
Simplify Asset Management Inc.45.41134.251+32,6%24.605.0423,19100 %7 Q
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND39.45040.530-2,7%21.375.1932,78100 %13 Q
Aware Super Pty Ltd as trustee of Aware Super34.20272.530-52,8%18.531.6702,41100 %7 Q
ARDSLEY ADVISORY PARTNERS LP30.00050.000-40,0%16.254.9002,11100 %3 Q
Erste Asset Management GmbH28.83126.664+8,1%15.710.1872,04100 %17 Q
Nepsis Inc.27.27342.194-35,4%14.777.3301,920 %8 Q
Asset Management One Co., Ltd.22.74223.722-4,1%12.322.2981,60100 %14 Q
Apollon Wealth Management, LLC22.58513.288+70,0%12.237.2311,5937 %2 Q
ASR Vermogensbeheer N.V.19.0471.221+1460,0%10.319.1621,34100 %6 Q
Resona Asset Management Co.,Ltd.15.39116.725-8,0%8.344.8921,08100 %10 Q
Y-Intercept (Hong Kong) Ltd14.2710+100,0%7.732.4561,00100 %7 Q
EVERGREEN CAPITAL MANAGEMENT LLC13.99213.120+6,6%7.581.2860,9877 %9 Q
YOUSIF CAPITAL MANAGEMENT, LLC12.44613.380-7,0%6.743.6160,8832 %17 Q
Louisiana State Employees Retirement System12.40012.500-0,8%6.718.6920,87100 %17 Q

Halter-Trend (6 Quartale)

PeriodeStatusHalterAnteile (Mio)Wert (Mio $)
30.06.2026vorl.2271,6783
31.03.202684544,724.884
31.12.202582446,021.204
30.09.202570541,916.559
30.06.202566044,211.877
31.03.202565945,913.022

Top 10 Neueinsteiger

FondsAnteileWert (USD)
VANGUARD CAPITAL MANAGEMENT LLC1.957.5391.160.781.476
BOWEN HANES & CO INC85.00050.403.300
Logos Global Management LP80.00047.438.400
MARSHALL WACE, LLP75.97745.052.842
Vestal Point Capital, LP75.00044.473.500
Aware Super Pty Ltd as trustee of Aware Super72.53043.008.839
ARDSLEY ADVISORY PARTNERS LP50.00029.649.000
Tidal Investments LLC33.46519.795.136
Hudson Bay Capital Management LP20.91812.403.956
SEB Asset Management AB17.73110.514.128

Top 10 Aufstocker

FondsAnteileΔ AnteileΔ %Wert (USD)
BlackRock, Inc.5.399.649228.883+4.4 %3.201.883.611
HRT FINANCIAL LP285.542222.145+350.4 %169.319
CITADEL ADVISORS LLC360.643173.479+92.7 %213.854.086
FIFTH THIRD BANCORP164.978164.519+35842.9 %97.828.539
Soleus Capital Management, L.P.187.187127.187+212.0 %110.998.147
FMR LLC528.346124.516+30.8 %313.298.624
BAILLIE GIFFORD & CO428.127105.111+32.5 %253.870.748
ACADIAN ASSET MANAGEMENT LLC300.20499.673+49.7 %177.976
FRANKLIN RESOURCES INC277.98396.863+53.5 %164.838.454
MILLENNIUM MANAGEMENT LLC153.37289.299+139.4 %90.946.529

Top 10 Verkäufer

FondsAnteileΔ AnteileΔ %Wert (USD)
AQR CAPITAL MANAGEMENT LLC826.226-455.473-35.5 %486.424.477
JANE STREET GROUP, LLC2.759-214.061-98.7 %1.636.032
D. E. Shaw & Co., Inc.99.106-207.865-67.7 %58.767.876
WELLINGTON MANAGEMENT GROUP LLP2.264.247-177.245-7.3 %1.342.653.186
VICTORY CAPITAL MANAGEMENT INC60.541-167.842-73.5 %35.899.602
RENAISSANCE TECHNOLOGIES LLC1.787.019-122.240-6.4 %1.059.666.527
Candriam S.C.A.63.066-64.149-50.4 %37.396.877
Nuveen, LLC190.697-61.112-24.3 %113.079.508
Tri Locum Partners LP70.370-50.551-41.8 %41.728.003
SEIZERT CAPITAL PARTNERS, LLC104.667-40.855-28.1 %62.065.438

Zusätzlich aktuell von 266 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →

Aktivisten & Großaktionäre (13D/13G)

DatumInvestorTypAnteilAktienΔΔ-Balken
30.04.2026Vanguard Capital ManagementPassiv (13G)5,19 %2.278.348Neu
27.03.2026The Vanguard GroupPassiv (13G/A)Ausstieg0-10,57 pp
10.02.2026Wellington Investment Advisors Holdings LLP (+2)Passiv (13G)5,70 %2.441.492+1,20 pp
12.05.2025Wellington Investment Advisors Holdings LLP (+2)Passiv (13G/A)4,50 %2.026.416-1,00 pp
10.02.2025Wellington Investment Advisors Holdings LLP (+2)Passiv (13G/A)5,50 %2.463.891-2,57 pp
05.02.2025STATE STREET CORPORATIONPassiv (13G)4,90 %2.199.994-0,10 pp
08.11.2024Martine A. RothblattPassiv (13G/A)6,80 %3.194.162-1,00 pp
16.10.2024STATE STREET CORPORATIONPassiv (13G)5,00 %2.238.224Neu
10.06.2024The Vanguard GroupPassiv (13G/A)10,57 %4.687.393+0,62 pp
14.02.2024Martine A. RothblattPassiv (13G/A)7,80 %3.900.308-0,20 pp
14.02.2024Avoro Capital Advisors LLC (+1)Passiv (13G/A)6,10 %2.858.888-0,20 pp
13.02.2024The Vanguard GroupPassiv (13G/A)9,95 %4.673.678+0,12 pp
13.02.2024RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734 (+1)Passiv (13G/A)4,62 %2.170.214-0,52 pp
08.02.2024Wellington Management Company LLPPassiv (13G/A)6,80 %3.195.591-1,69 pp
08.02.2024Wellington Investment Advisors Holdings LLP (+2)Passiv (13G/A)8,07 %3.794.010-1,94 pp
24.01.2024. BlackRock, Inc.Passiv (13G/A)11,30 %5.294.844+1,10 pp
10.07.2023Wellington Management Company LLPPassiv (13G/A)8,49 %3.979.471Neu
10.07.2023Wellington Investment Advisors Holdings LLP (+2)Passiv (13G/A)10,01 %4.688.824+4,37 pp
08.03.2023. BlackRock, Inc.Passiv (13G/A)10,20 %4.726.986+0,30 pp
14.02.2023Avoro Capital Advisors LLC (+1)Passiv (13G/A)6,30 %2.865.000-0,40 pp
13.02.2023RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734 (+1)Passiv (13G/A)5,14 %2.344.492-1,34 pp
09.02.2023The Vanguard GroupPassiv (13G/A)9,83 %4.480.719+0,59 pp
06.02.2023Wellington Investment Advisors Holdings LLP (+2)Passiv (13G)5,64 %2.569.263Neu
02.02.2023Martine A. RothblattPassiv (13G/A)8,00 %3.919.603-0,50 pp
24.01.2023. BlackRock, Inc.Passiv (13G/A)9,90 %4.510.211+0,50 pp
11.02.2022RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734 (+1)Passiv (13G/A)6,48 %2.917.191-1,64 pp
11.02.2022Avoro Capital Advisors LLC (+1)Passiv (13G/A)6,70 %3.035.000+0,30 pp
10.02.2022The Vanguard GroupPassiv (13G/A)9,24 %4.160.963+0,32 pp
04.02.2022Martine A. RothblattPassiv (13G/A)8,50 %4.118.487+0,90 pp
03.02.2022. BlackRock, Inc.Passiv (13G/A)9,40 %4.239.175-0,20 pp

US Congress Trades (STOCK Act)

DatumMitgliedParteiKammerTypBetrag-Bereich
31.10.2025Lisa McClainHouseVerkauf$1,001 – $15,000
30.10.2025Lisa McClainHouseVerkauf$1,001 – $15,000
30.10.2025Lisa McClainHouseKauf$1,001 – $15,000
11.06.2025Lisa McClainHouseKauf$1,001 – $15,000

Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →

Finanzkennzahlen (SEC XBRL)

Währung:
PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-03-3110-Q274.900.000 $5,82 $6.714.200.000 $5.901.100.000 $
2025-12-3110-K1.334.700.000 $27,86 $7.880.000.000 $7.096.200.000 $
2025-09-3010-Q338.700.000 $7,16 $7.351.100.000 $6.590.200.000 $
2025-06-3010-Q309.500.000 $6,41 $7.908.000.000 $7.173.600.000 $
2025-03-3110-Q322.200.000 $6,63 $7.743.900.000 $6.807.200.000 $
2024-12-3110-K1.195.100.000 $24,64 $7.364.000.000 $6.444.000.000 $
2024-09-3010-Q309.100.000 $6,39 $7.123.100.000 $6.100.900.000 $
2024-06-3010-Q278.100.000 $5,85 $6.723.200.000 $5.697.200.000 $
2024-03-3110-Q306.600.000 $6,17 $6.495.200.000 $5.338.100.000 $
2023-12-3110-K984.800.000 $19,81 $7.167.000.000 $5.984.800.000 $
2023-09-3010-Q267.600.000 $5,38 $7.023.600.000 $5.712.100.000 $
2023-06-3010-Q259.200.000 $5,24 $6.681.300.000 $5.411.000.000 $
2023-03-3110-Q240.900.000 $4,86 $6.346.000.000 $5.123.200.000 $
2022-12-3110-K727.300.000 $15,00 $6.044.500.000 $4.796.700.000 $
2022-09-3010-Q239.300.000 $4,91 $5.781.600.000 $4.562.200.000 $
2022-06-3010-Q116.000.000 $2,41 $5.543.300.000 $4.318.400.000 $
2022-03-3110-Q239.900.000 $5,03 $5.359.800.000 $4.176.300.000 $
2021-12-3110-K475.800.000 $10,06 $5.169.100.000 $3.958.900.000 $
2021-09-3010-Q162.700.000 $3,42 $5.048.900.000 $3.829.700.000 $
2021-06-3010-Q172.600.000 $3,65 $4.844.900.000 $3.639.500.000 $

Umsatz nach Segmenten & Regionen

Geschäftssegmente

SegmentFY 2025FY 2024FY 2023FY 2022FY 2021AnteilΔTrend
Tyvaso1,9 Mrd.1,6 Mrd.1,2 Mrd.873,0 Mio.607,5 Mio.59,0 %+15,9%
Tyvaso DPI1,3 Mrd.1,0 Mrd.731,1 Mio.40,6 %+25,0%
Nebulized Tyvaso585,7 Mio.586,8 Mio.502,6 Mio.18,4 %-0,2%
Remodulin526,8 Mio.538,1 Mio.494,8 Mio.500,2 Mio.513,7 Mio.16,6 %-2,1%
Orenitram496,9 Mio.434,3 Mio.359,4 Mio.325,1 Mio.306,1 Mio.15,6 %+14,4%
Unituxin226,8 Mio.238,7 Mio.198,9 Mio.182,9 Mio.202,3 Mio.7,1 %-5,0%
Adcirca30,0 Mio.23,8 Mio.28,9 Mio.41,3 Mio.55,9 Mio.0,9 %+26,1%
Product And Service Other24,0 Mio.22,1 Mio.11,8 Mio.13,8 Mio.0,8 %+8,6%

Quartalsverlauf

SegmentQ3 FY2025Q2 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q1 FY2024AnteilΔTrend
Tyvaso478,0 Mio.469,6 Mio.466,3 Mio.433,8 Mio.398,2 Mio.372,5 Mio.59,8 %+10,2%
Tyvaso DPI336,2 Mio.315,2 Mio.302,5 Mio.274,6 Mio.258,3 Mio.227,5 Mio.42,1 %+22,4%
Nebulized Tyvaso141,8 Mio.154,4 Mio.163,8 Mio.159,2 Mio.139,9 Mio.145,0 Mio.17,7 %-10,9%
Orenitram131,1 Mio.123,9 Mio.120,7 Mio.113,2 Mio.107,1 Mio.106,2 Mio.16,4 %+15,8%
Remodulin125,9 Mio.134,7 Mio.138,2 Mio.128,3 Mio.147,3 Mio.128,0 Mio.15,7 %-1,9%
Unituxin47,9 Mio.58,4 Mio.58,2 Mio.61,1 Mio.51,7 Mio.58,4 Mio.6,0 %-21,6%
Adcirca9,7 Mio.6,5 Mio.6,0 Mio.7,0 Mio.5,7 Mio.6,4 Mio.1,2 %+38,6%
Product And Service Other6,9 Mio.5,5 Mio.5,0 Mio.5,5 Mio.4,9 Mio.6,2 Mio.0,9 %+25,5%

Regionen

RegionFY 2025FY 2024FY 2023FY 2022FY 2021AnteilΔTrend
US3,0 Mrd.2,7 Mrd.2,2 Mrd.1,8 Mrd.1,6 Mrd.95,4 %+10,9%
Non Us145,7 Mio.137,7 Mio.125,3 Mio.122,2 Mio.121,3 Mio.4,6 %+5,8%

Quartalsverlauf

RegionQ3 FY2025Q2 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q1 FY2024AnteilΔTrend
US774,8 Mio.759,8 Mio.749,6 Mio.717,3 Mio.675,2 Mio.641,5 Mio.96,9 %+8,0%
Non Us24,7 Mio.38,8 Mio.44,8 Mio.31,6 Mio.39,7 Mio.36,2 Mio.3,1 %-21,8%

Quartalsergebnisse (Earnings)

QuartalStichtagVerkündetUmsatzEPS
Q1 202631.03.202606.05.2026781,5 Mio. USD5,82
Q3 202530.09.202529.10.2025799,5 Mio. USD7,16
Q2 202530.06.202530.07.2025798,6 Mio. USD6,41
Q1 202531.03.202530.04.2025794,4 Mio. USD6,63
Q3 202430.09.202430.10.2024748,9 Mio. USD6,39
Q2 202430.06.202431.07.2024714,9 Mio. USD5,85
Q1 202431.03.202401.05.2024677,7 Mio. USD6,17
Q3 202330.09.202301.11.2023609,4 Mio. USD5,38
Q2 202330.06.202302.08.2023596,5 Mio. USD5,24

Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)

SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag, SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte (20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die Tage zwischen Berichtsstichtag und tatsächlicher Einreichung. Suffix /A kennzeichnet nachträgliche Berichtigungen.

Eingereicht (US)FormBerichtsperiodeVerzögerung
06.05.202610-Q31.03.202636 TageSEC »
25.02.202610-K31.12.202556 TageSEC »
29.10.202510-Q30.09.202529 TageSEC »
30.07.202510-Q30.06.202530 TageSEC »
30.04.202510-Q31.03.202530 TageSEC »
26.02.202510-K31.12.202457 TageSEC »
30.10.202410-Q30.09.202430 TageSEC »
31.07.202410-Q30.06.202431 TageSEC »
01.05.202410-Q31.03.202431 TageSEC »
21.02.202410-K31.12.202352 TageSEC »
01.11.202310-Q30.09.202332 TageSEC »
02.08.202310-Q30.06.202333 TageSEC »
03.05.202310-Q31.03.202333 TageSEC »
22.02.202310-K31.12.202253 TageSEC »
02.11.202210-Q30.09.202233 TageSEC »
03.08.202210-Q30.06.202234 TageSEC »
04.05.202210-Q31.03.202234 TageSEC »
24.02.202210-K31.12.202155 TageSEC »
03.11.202110-Q30.09.202134 TageSEC »
04.08.202110-Q30.06.202135 TageSEC »
05.05.202110-Q31.03.202135 TageSEC »
24.02.202110-K31.12.202055 TageSEC »
28.10.202010-Q30.09.202028 TageSEC »
29.07.202010-Q30.06.202029 TageSEC »

Proxy-/Governance-Filings

Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.

Datum (US)KategorieHV-Termin (US)Stichtag (US)Form
29.04.2026HV-EinladungDEFA14ASEC »
29.04.2026HV-Einladung26.06.2026 Jahres-HV28.04.2026DEF 14ASEC »
29.04.2025HV-EinladungDEFA14ASEC »
29.04.2025HV-Einladung26.06.2025 Jahres-HV28.04.2025DEF 14ASEC »
29.04.2024HV-EinladungDEFA14ASEC »
29.04.2024HV-Einladung26.06.2024 Jahres-HV29.04.2024DEF 14ASEC »
28.04.2023HV-EinladungDEFA14ASEC »
28.04.2023HV-EinladungDEF 14ASEC »
29.04.2022HV-EinladungDEFA14ASEC »
29.04.2022HV-Einladung27.06.2022 Jahres-HV28.04.2022DEF 14ASEC »
10.09.2021HV-EinladungDEFA14ASEC »
19.08.2021HV-EinladungDEFA14ASEC »
19.08.2021HV-Einladung30.09.2021 a.o. HV10.08.2021DEF 14ASEC »
04.08.2021HV-EinladungDEFA14ASEC »
14.07.2021VorläufigPRE 14ASEC »
17.06.2021HV-EinladungDEFA14ASEC »
29.04.2021HV-EinladungDEFA14ASEC »
29.04.2021HV-Einladung25.06.2021 Jahres-HV30.04.2021DEF 14ASEC »
29.04.2021HV-EinladungDEFA14ASEC »

Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).

Übernahmen & Fusionen (M&A)

M&A-relevante SEC-Filings der letzten sechs Jahre: Übernahmeangebote (Tender Offers), Fusionen (425/S-4), Aktienrückkauf-Angebote (Self-Tender) und Going-Private-Transaktionen. Geführt nach dem einreichenden Emittenten.

Datum (US)KategorieFormDeal-KonditionenSEC
13.12.2023ÜbernahmeangebotSC TO-T/ASEC »
12.12.2023ÜbernahmeangebotSC TO-T/ASEC »
04.12.2023ÜbernahmeangebotSC TO-T/ASEC »
13.11.2023ÜbernahmeangebotSC TO-T$3,25 CashSEC »
01.11.2023ÜbernahmeangebotSC TO-CSEC »
30.10.2023ÜbernahmeangebotSC TO-CSEC »
30.10.2023ÜbernahmeangebotSC TO-CSEC »

Datum = US-Einreichungsdatum (SEC EDGAR, ET). Deal-Konditionen aus dem Dokument extrahiert (Tender: SC TO-T/-I/SC 14D9; Fusion: 425/S-4 — Gegenpartei + Umtauschverhältnis), ohne Gewähr — Original siehe SEC-Link.

Kritische 8-K Meldungen

WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (23.07.2026)
DatumMeldungTagsSchwereFilingAuszug
23.07.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
22.01.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSEC          Item 5.02.               Departure of Directors or Certain Officers; Election of Directors; Appointment of…

8-K-Ereignisse (KI)

🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.

DatumEreignisSentimentMaterialitätZusammenfassungFiling
23.07.2026Personalwechsel0,0050United Therapeutics hat Victor Dzau, MD als neues Mitglied des Vorstands ernannt und ihm Anrechte unter dem Aktienincentivierungsplan verlie… 🔒SEC
29.06.2026HV-Abstimmung0,0040Die Aktionäre von United Therapeutics genehmigten am 26. Juni 2026 das neue Stock Incentive Plan 2026, das zur Verwaltung von Aktienvergütun… 🔒SEC
06.05.2026Quartalszahlen0,0040United Therapeutics veröffentlichte Geschäftsergebnisse für Q1 2026 (Quartal endend 31. März 2026). Konkrete Zahlen und deren Impact nicht a… 🔒SEC
30.03.2026Sonstiges0,6070United Therapeutics meldete positive Ergebnisse der TETON-1-Studie für Tyvaso® bei idiopathischer Lungenfibrose. Die Daten könnten zur Zulas… 🔒SEC
09.03.2026Wesentliche Vereinbarung0,6870United Therapeutics kündigte ein 2-Milliarden-Dollar-Aktienrückkaufprogramm an, das bis März 2027 läuft, zusammen mit zwei beschleunigten Rü… 🔒SEC
02.03.2026Guidance-Update0,7578United Therapeutics kündigte positive Ergebnisse der ADVANCE OUTCOMES-Studie von Ralinepag bei Patienten mit pulmonaler arterieller Hyperton… 🔒SEC
25.02.2026Quartalszahlen0,0050United Therapeutics veröffentlichte am 25. Februar 2026 Finanzzergebnisse und Business Updates für das Geschäftsjahr 2025.SEC
22.01.2026Personalwechsel0,0015United Therapeutics erhöhte die Größe des Board of Directors auf 13 Mitglieder. Dies ist eine administrative Governance-Änderung ohne direkt… 🔒SEC

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-06-303.068544,921.671.815
2026-06-18844551,47465.441
2026-06-17684548,27375.017
2026-06-168.926549,574.905.462
2026-06-1548545,9626.206
2026-06-08987549,87542.722
2026-06-04614549,47337.375
2026-05-282570,751.142
2026-05-199.277566,995.259.966

Hinweis

Erweitert ×